Pseudohyponatremia of Multiple Myeloma is True Hyponatremia
NCT01425606 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2011-08-30
Summary
Hypothesis: the hyponatremia of multiple myeloma (m.m.)is true and not pseudohyponatremia by using the stewart approach to acid - base interpretation, would like to show that the positive charged m- proteins produced in m.m.result in true hyponatremia.
Conditions
- Hyponatremia of Multiple Myeloma
Interventions
- OTHER
-
blood test
blood test to measure levels of: sodium, albumin and acid - base status in venous blood.
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
NCT05918185 ·Status: COMPLETED
-
A Multiple Myeloma Trial in Patients With Bone Metastases
NCT00104104 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
NCT05561387 ·Status: RECRUITING ·Phase: PHASE3
-
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
NCT00919139 ·Status: COMPLETED
-
Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol)
NCT01802658 ·Status: TERMINATED ·Phase: PHASE3
-
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
NCT00900263 ·Status: COMPLETED
-
Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
NCT02669615 ·Status: COMPLETED ·Phase: PHASE2
-
Sleep Apnea in Patients With MGUS and MM
NCT04114084 ·Status: RECRUITING
-
Plasma-free Replacement in Patients With Multiple Myeloma
NCT05251896 ·Status: COMPLETED ·Phase: NA
-
Integrative Therapies in Multiple Myeloma
NCT06515249 ·Status: RECRUITING ·Phase: NA
-
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
NCT00242528 ·Status: WITHDRAWN ·Phase: PHASE4
-
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
NCT01345019 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002653 ·Status: UNKNOWN ·Phase: PHASE3
-
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
NCT00432458 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
NCT04597931 ·Status: UNKNOWN ·Phase: PHASE4
-
A Dietary Study for People With Multiple Myeloma
NCT07226609 ·Status: RECRUITING ·Phase: NA
-
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
NCT06457464 ·Status: NOT_YET_RECRUITING
-
Role of Uromodulin in Management of Multiple Myloma
NCT06876298 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
NCT06365060 ·Status: RECRUITING
-
Clinical Evaluation of the Serum Free Light Chain Analysis
NCT01423344 ·Status: UNKNOWN
-
Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00002678 ·Status: COMPLETED ·Phase: PHASE3
-
Etiology of Multiple Myeloma: A Case-Control Study
NCT00505999 ·Status: UNKNOWN
-
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
NCT06149910 ·Status: RECRUITING
-
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
NCT00983346 ·Status: TERMINATED ·Phase: PHASE2
-
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00602641 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3